French biopharma Ipsen and US-based Marengo Therapeutics have formed a strategic partnership that aims to advance two of Marengo’s preclinical immuno-oncology candidates...
20.04.2020
- The worldwide spread of the corona virus shows once again that despite all technological progress, humanity is still exposed to health risks. The biotech and pharmaceutical...
14.10.2019
- Major UK drugmaker GlaxoSmithKline (GSK) has announced a five-year collaboration with US biotech Lyell Immunopharma to develop new technologies to improve cell therapies for cancer...
06.02.2019
- German and British drugmakers Merck KGaA and Glaxo SmoithKline have entered a global strategic alliance to jointly develop and commercialize M7824 (bintrafusp alfa), the German...
14.12.2018
- US biopharma AVEO Oncology is collaborating with Anglo-Swedish drug major AstraZeneca on a combined treatment for liver cancer. The partners will evaluate the safety and efficacy...
01.03.2018
- The US Food and Drug Administration (FDA) has approved AstraZeneca and MedImmune’s immunotherapy Imfinzi (durvalumab) to treat patients with a certain form of lung cancer. Imfinzi...
07.12.2017
- The US Food and Drug Administration (FDA) has given the green light to Netherlands-domiciled, US-managed generic drugmaker Mylan’s Ogivri (trastuzumab-dkst) breast cancer drug, a...
